200 related articles for article (PubMed ID: 38259462)
1. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors.
Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT
Front Immunol; 2023; 14():1334800. PubMed ID: 38259462
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
[TBL] [Abstract][Full Text] [Related]
3. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
[TBL] [Abstract][Full Text] [Related]
4. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages.
Fernández-Mariño I; Anfray C; Crecente-Campo J; Maeda A; Ummarino A; Teijeiro-Valiño C; Blanco-Martinez D; Mpambani F; Poul L; Devalliere J; Germain M; Correa J; Fernandez-Villamarin M; Allavena P; Fernandez-Megia E; Alonso MJ; Andón FT
Drug Deliv Transl Res; 2023 Jul; 13(7):1896-1911. PubMed ID: 36472784
[TBL] [Abstract][Full Text] [Related]
5. Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors.
Dacoba TG; Anfray C; Mainini F; Allavena P; Alonso MJ; Torres Andón F; Crecente-Campo J
Front Immunol; 2020; 11():1412. PubMed ID: 32733469
[No Abstract] [Full Text] [Related]
6. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
[TBL] [Abstract][Full Text] [Related]
7. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
Ye J; Mills BN; Qin SS; Garrett-Larsen J; Murphy JD; Uccello TP; Han BJ; Vrooman TG; Johnston CJ; Lord EM; Belt BA; Linehan DC; Gerber SA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851308
[TBL] [Abstract][Full Text] [Related]
9. Enhancing antibody-dependent cellular phagocytosis by Re-education of tumor-associated macrophages with resiquimod-encapsulated liposomes.
Li H; Somiya M; Kuroda S
Biomaterials; 2021 Jan; 268():120601. PubMed ID: 33338932
[TBL] [Abstract][Full Text] [Related]
10. Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8
Zhang X; Wei Z; Yong T; Li S; Bie N; Li J; Li X; Liu H; Xu H; Yan Y; Zhang B; Chen X; Yang X; Gan L
Nat Commun; 2023 Sep; 14(1):5653. PubMed ID: 37704614
[TBL] [Abstract][Full Text] [Related]
11. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
12. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
13. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages.
Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H
Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethylated Alginate-Resiquimod Micelles Reverse the Immunosuppressive Tumor Microenvironment and Synergistically Enhance the Chemotherapy and Immunotherapy for Gastric Cancer.
Chen J; Liu X; Zhao S; Chen H; Lu T; Wang J; Han J; Wu W; Shen X; Li C
ACS Appl Mater Interfaces; 2023 Aug; 15(30):35999-36012. PubMed ID: 37477904
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy.
Kang Y; Lim J; Saravanakumar G; Kim J; Park M; Im S; Kim WJ
J Control Release; 2022 Mar; 343():78-88. PubMed ID: 35065158
[TBL] [Abstract][Full Text] [Related]
16. Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer.
Glass EB; Hoover AA; Bullock KK; Madden MZ; Reinfeld BI; Harris W; Parker D; Hufnagel DH; Crispens MA; Khabele D; Rathmell WK; Rathmell JC; Wilson AJ; Giorgio TD; Yull FE
BMC Cancer; 2022 May; 22(1):497. PubMed ID: 35513776
[TBL] [Abstract][Full Text] [Related]
17. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
Jing Z; Li Y; Song J; Zang X
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
[TBL] [Abstract][Full Text] [Related]
18. Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.
Rodell CB; Ahmed MS; Garris CS; Pittet MJ; Weissleder R
Theranostics; 2019; 9(26):8426-8436. PubMed ID: 31879528
[TBL] [Abstract][Full Text] [Related]
19. Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.
Yuan H; Gui H; Chen S; Zhu L; Wang C; Jing Q; Lv H; Wan Q; Wang S; Zhou S; Ren X; Nie Y; Li L
Int J Nanomedicine; 2024; 19():3589-3605. PubMed ID: 38645464
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using
Kim HY; Li R; Ng TSC; Courties G; Rodell CB; Prytyskach M; Kohler RH; Pittet MJ; Nahrendorf M; Weissleder R; Miller MA
ACS Nano; 2018 Dec; 12(12):12015-12029. PubMed ID: 30508377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
